InvestorsHub Logo
Followers 12
Posts 619
Boards Moderated 0
Alias Born 12/14/2018

Re: flipper44 post# 211593

Friday, 02/01/2019 12:06:35 PM

Friday, February 01, 2019 12:06:35 PM

Post# of 693452
Was there more to their announcement that this?

Northwest Biotherapeutics, Inc. (the “Company”) is unable to complete the Form 10-Q on time because it is in late stage parallel negotiations with different unrelated third parties in regard to substantial alternative potential financings, and the Company anticipates the accounting and disclosure could be impacted by the completion of this process.



I’m not seeing multinationals mentioned. Did they say that somewhere else?

$47 million seems substantial to a $100 million micro cap.

A sale of real estate seems to qualify as an alternative source of financing - not aware that they’ve ever done that before.

The reason for the announcement is that the filing is delayed because the transaction would impact the accounting— seems like a reasonable possibility.

I’m not seeing NWBO playing up something here that ultimately didn’t essentially match what they said. What piece am I missing?

Was it the war chest comment? That PR announcing the transaction seemed relatively reasonable to me, at least I don’t feel misled by it:


https://nwbio.com/nw-bio-announces-that-uk-property-transaction-has-closed-including-funding-of-approximately-47-3-million-gross-proceeds/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News